Observational Examination of Thermoregulation in Total Joint Arthroplasty

Sponsor
Medical University of South Carolina (Other)
Overall Status
Completed
CT.gov ID
NCT02225743
Collaborator
(none)
120
1
10
12

Study Details

Study Description

Brief Summary

Total joint patients have poor outcomes with infection since they are having permanent hardware implanted. Infection prevention in this group is therefore critical and a major source of discussion in both the orthopedic and anesthesia literature.

Hypothermia has been shown to increase the risk of infection and blood loss. However, studies have not examined when in the operation or how fast patients temperatures drop. This study will observe how patients' temperatures change during total joint arthroplasty. By identifying when body temperature changes occur, prevention strategies may be developed and implemented.

Condition or Disease Intervention/Treatment Phase
  • Other: Observation Of Temperature

Detailed Description

Peri-operative hypothermia can have deleterious effects. While there is no standard consistent definition within the literature mild hypothermia is commonly defined as a core temperature between 34 and 36 °C. Mild hypothermia has been shown to increase the occurrence of surgical site infections, cardiac morbidity, coagulopathy leading to increased blood loss and transfusion requirements, impaired drug metabolism, and prolonged emergence from anesthesia. In addition, there is evidence that maintaining intra-operative normothermia can shorten hospital length of stay. Despite the fact that intra-operative temperature monitoring and warming are considered standard of care, peri-operative hypothermia in total joint arthroplasty patients remains an issue for several reasons. A large proportion of patient undergoing joint replacement are elderly, making them susceptible to peri-operative hypothermia. In addition, regional anesthesia causes vasodilation and promotes heat flow from the core to the periphery and impairs central and autonomic thermoregulation such that patients receiving neuraxial anesthesia can be particularly susceptible to perioperative hypothermia. Finally, core temperature monitoring is typically not used during regional anesthesia and hypothermia may go undetected for long periods of time.

The primary goal of this study was to examine the incidence of hypothermia during lower extremity arthroplasty. A secondary aim was to identify patient and operative factors associated with hypothermia in order to improve future preventative strategies. Our hypothesis was that peri-operative hypothermia occurs in the majority of patients undergoing lower extremity arthroplasty. In addition, we hypothesized that certain patient and anesthetic factors (such as low body mass index and receiving general anesthesia) would increase the incidence of hypothermia.

Study Design

Study Type:
Observational
Actual Enrollment :
120 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Observational Examination of Thermoregulation in Total Joint Arthroplasty
Study Start Date :
Aug 1, 2014
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Joint Arthroplasty

Participants undergoing joint replacement

Other: Observation Of Temperature
Participants temperature will be recorded perioperatively.

Outcome Measures

Primary Outcome Measures

  1. Incidence of Hypothermia [Starting with temperature measurement prior to leaving preoperative holding for OR and ending after temperature taken on arrival in recovery room]

    The incidence of ever being hypothermic (temperature < 36.0 °C at one or more measurements) was the primary outcome. All temperatures were assessed with an Exergen temporal thermometer (precise to 0.1 °C). Each temporal measurement was taken and recorded three times for accuracy and the mean value utilized for data analysis at each time point. Temperatures were measured upon (1) leaving holding area; (2) operating room (OR) arrival; (3) after anesthetic induction; (4) upper body forced air warmer initiation (used for all patients); (5) incision; (6-8) every 30 minutes after incision; (9) leaving the OR; and (10) arrival to PACU. OR temperature and humidity were recorded throughout.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults 18 years of age and over that are scheduled to undergo total hip or total knee joint arthroplasty.
Exclusion Criteria:
  • Patients unable to give informed consent will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of South Carolina Charleston South Carolina United States 29425

Sponsors and Collaborators

  • Medical University of South Carolina

Investigators

  • Principal Investigator: Sylvia H Wilson, MD, Medical University of South Carolina
  • Study Director: Wanda Jones, Medical University of South Carolina

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT02225743
Other Study ID Numbers:
  • Thermoregulation Total Joint
  • Pro00035290
First Posted:
Aug 26, 2014
Last Update Posted:
Jan 24, 2019
Last Verified:
Jan 1, 2019
Keywords provided by Medical University of South Carolina
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Joint Arthroplasty
Arm/Group Description Participants undergoing joint replacement Observation Of Temperature: Participants temperature will be recorded perioperatively.
Period Title: Overall Study
STARTED 120
COMPLETED 102
NOT COMPLETED 18

Baseline Characteristics

Arm/Group Title Joint Arthroplasty
Arm/Group Description Participants undergoing joint replacement Observation Of Temperature: Participants temperature will be recorded perioperatively.
Overall Participants 102
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
63.5
(11.3)
Sex: Female, Male (Count of Participants)
Female
64
62.7%
Male
38
37.3%
Total Knee Arthroplasty (Count of Participants)
Count of Participants [Participants]
54
52.9%

Outcome Measures

1. Primary Outcome
Title Incidence of Hypothermia
Description The incidence of ever being hypothermic (temperature < 36.0 °C at one or more measurements) was the primary outcome. All temperatures were assessed with an Exergen temporal thermometer (precise to 0.1 °C). Each temporal measurement was taken and recorded three times for accuracy and the mean value utilized for data analysis at each time point. Temperatures were measured upon (1) leaving holding area; (2) operating room (OR) arrival; (3) after anesthetic induction; (4) upper body forced air warmer initiation (used for all patients); (5) incision; (6-8) every 30 minutes after incision; (9) leaving the OR; and (10) arrival to PACU. OR temperature and humidity were recorded throughout.
Time Frame Starting with temperature measurement prior to leaving preoperative holding for OR and ending after temperature taken on arrival in recovery room

Outcome Measure Data

Analysis Population Description
Ever hypothermic (temperature <36.0 degrees C) during the perioperative period
Arm/Group Title Hypothermia
Arm/Group Description Hypothermia was defined as a temperature less than 36.0 °C. .
Measure Participants 102
Count of Participants [Participants]
74
72.5%

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Joint Arthroplasty
Arm/Group Description Participants undergoing joint replacement Observation Of Temperature: Participants temperature will be recorded perioperatively.
All Cause Mortality
Joint Arthroplasty
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
Joint Arthroplasty
Affected / at Risk (%) # Events
Total 0/102 (0%)
Other (Not Including Serious) Adverse Events
Joint Arthroplasty
Affected / at Risk (%) # Events
Total 0/102 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Sylvia Wilson, MD
Organization Medical University of South Carolina
Phone 843-792-2322
Email wilsosh@musc.edu
Responsible Party:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT02225743
Other Study ID Numbers:
  • Thermoregulation Total Joint
  • Pro00035290
First Posted:
Aug 26, 2014
Last Update Posted:
Jan 24, 2019
Last Verified:
Jan 1, 2019